subject: PUBCHEM.COMPOUND:122197547

subject_name: VOXILAPREVIR


subject: CHEBI:90881

subject_name: Camptosar

object_name: Childhood Solid Neoplasm

tested_intervention: unsure


subject: CHEBI:90881

object_name: Adult Solid Neoplasm


subject: CHEBI:90881

object_name: Solid Neoplasm


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:46058


subject: CHEBI:46058


subject: UMLS:C5432325

object_name: uveitis

tested_intervention: yes


subject: UMLS:C5432325

object_name: Uveitis, CTCAE


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Overactive Detrusor


subject: UNII:KX89J0DFZ8

subject_name: IMSIDOLIMAB

object_name: acne


subject: UMLS:C0249056


subject: UMLS:C1550506

subject_name: product - ParticipationType

object_name: stroke disorder


subject: UMLS:C1550506

object_name: cerebrovascular disorder


subject: UMLS:C1550506

object_name: Stroke (heart beat)


subject: UMLS:C1550506

object_name: Stroke, CTCAE


subject: UMLS:C1550506

object_name: Spasticity as sequela of stroke


subject: UMLS:C1550506

object_name: spastic hemiplegia


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Postoperative Complications


subject: UNII:72W09924WP

subject_name: Asoprisnil

object_name: Menorrhagia


subject: UNII:72W09924WP

object_name: Menorrhagia, CTCAE


subject: CHEBI:114785

subject_name: Erlotinib

object_name: liver cancer


subject: CHEBI:114785

object_name: liver neoplasm


subject: CHEBI:114785

object_name: Adult Liver Carcinoma


subject: CHEBI:52763

object_name: internal hemorrhoid


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Fetal or neonatal effect of induction of labor


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:5779

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:5779

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:5779

object_name: Malignant Solid Neoplasm


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:6444

subject_name: Levorphanol


subject: CHEBI:6444


subject: CHEBI:6444


subject: CHEBI:6444


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7865

subject_name: Oxymorphone


subject: CHEBI:7865


subject: CHEBI:7865


subject: CHEBI:7865


subject: CHEBI:8499

subject_name: Propranolol

object_name: Gastric varix


subject: CHEBI:184662

object_name: HIV Coinfection


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:86431

subject_name: Sodium fluorophosphate

object_name: dental caries


subject: CHEBI:86431

object_name: Dental Caries, CTCAE


subject: UMLS:C5554922

subject_name: Anti-TREM1 Agonistic Monoclonal Antibody PY159

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5554922

object_name: Neck Carcinoma


subject: UMLS:C5554922

object_name: head and neck neoplasm


subject: UMLS:C5554922

object_name: head and neck cancer


subject: UMLS:C5554922

object_name: pancreatic neoplasm


subject: UMLS:C5554922

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5554922

object_name: malignant pancreatic neoplasm


subject: UMLS:C5554922

object_name: colorectal cancer


subject: UMLS:C5554922

object_name: colorectal carcinoma


subject: UMLS:C5554922

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5554922

object_name: gastric adenocarcinoma


subject: UMLS:C5554922

object_name: female reproductive organ cancer


subject: UMLS:C5554922

object_name: lung adenocarcinoma


subject: UMLS:C5554922

object_name: Childhood Breast Carcinoma


subject: UMLS:C5554922

object_name: breast carcinoma


subject: UMLS:C5554922

object_name: breast cancer


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315001

subject_name: TOBEMSTOMIG

object_name: non-small cell lung carcinoma


subject: CHEBI:166679

subject_name: Retapamulin

object_name: atopic eczema


subject: UNII:4MG6O8991R


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: UMLS:C4688609

subject_name: SEL 110

object_name: Mesothelioma


subject: UMLS:C4688609

object_name: mesothelial neoplasm


subject: UMLS:C4688609

object_name: malignant mesothelioma


subject: UMLS:C3273697

subject_name: Colloidal Oatmeal Cream


subject: UMLS:C3273697

object_name: dermatitis


subject: UMLS:C3273697

object_name: Eczema, CTCAE


subject: UMLS:C4330704


subject: CHEBI:45783

subject_name: Imatinib

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:45783

object_name: Chronic myeloid leukemia, BCR/ABL-positive, in remission


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:52172


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: conjunctivitis


subject: CHEBI:465284

object_name: Conjunctivitis, CTCAE


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: change; circulatory


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: UMLS:C4722367

object_name: prostate carcinoma


subject: UMLS:C4722367

object_name: prostate cancer


subject: UMLS:C4722367

object_name: neoplasm


subject: CHEBI:229496

subject_name: N-omega-carboxyethyl-L-arginine

object_name: lung cancer


subject: CHEBI:229496

object_name: lung neoplasm


subject: CHEBI:229496

object_name: lung carcinoma


subject: CHEBI:229496

object_name: colon carcinoma


subject: CHEBI:229496

object_name: colorectal cancer


subject: CHEBI:229496

object_name: colon cancer


subject: CHEBI:229496


subject: CHEBI:229496


subject: CHEBI:229496

object_name: Childhood Breast Carcinoma


subject: CHEBI:229496

object_name: breast carcinoma


subject: CHEBI:229496

object_name: breast cancer


subject: CHEBI:229496


subject: PR:000001330

subject_name: cell adhesion molecule CEACAM5


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: PR:000001330


subject: UMLS:C0007082

subject_name: Carcinoembryonic Antigen


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0007082


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Cirrhosis


subject: CHEBI:7986

object_name: liver failure


subject: UMLS:C1831918

object_name: Chemotherapy-induced nausea and vomiting


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: Non-small cell lung cancer stage III


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: schizophreniform disorder


subject: CHEBI:66910

subject_name: Axitinib

object_name: Unresectable Renal Cell Carcinoma


subject: GTOPDB:8313

subject_name: talazoparib

object_name: renal carcinoma


subject: GTOPDB:8313

object_name: kidney neoplasm


subject: GTOPDB:8313

object_name: kidney cancer


subject: GTOPDB:8313

object_name: Metastatic Renal Cell Carcinoma


subject: GTOPDB:8313

object_name: Metastatic Renal Cell Cancer


subject: GTOPDB:8313


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: Ischemia Cerebrovascular, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEBI:4875

subject_name: Etanercept

object_name: Primary gout


subject: CHEBI:4875

object_name: Gout attack


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: UMLS:C0370003

subject_name: Specimen

object_name: non-small cell lung carcinoma


subject: UMLS:C1709546

subject_name: Bioperine

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: fibromyalgia


subject: CHEBI:71219

subject_name: Pazopanib

object_name: hereditary hemorrhagic telangiectasia


subject: CHEBI:71219

object_name: Epistaxis, CTCAE


subject: CHEBI:71219

object_name: Epistaxis


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: chronic prostatitis


subject: PR:000017503

subject_name: solute carrier family 53 member 1

object_name: HIV infection


subject: PR:000006336

subject_name: L-xylulose reductase


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:23965

subject_name: estradiol

object_name: coronary artery disorder


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:6427

subject_name: Leuprolide


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: benign neoplasm of parathyroid gland


subject: PUBCHEM.COMPOUND:6096882

object_name: malignant tumor of parathyroid gland


subject: PUBCHEM.COMPOUND:6096882

object_name: Neoplasm of uncertain or unknown behavior of parathyroid gland


subject: PUBCHEM.COMPOUND:6096882

object_name: thyroid disease


subject: PUBCHEM.COMPOUND:6096882

object_name: reported prior thyroid disease (history)


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:91402

subject_name: linsitinib

object_name: adrenal carcinoma


subject: CHEBI:91402

object_name: adrenal cortex carcinoma


subject: UMLS:C2346449

subject_name: OSI 906


subject: UMLS:C2346449


subject: CHEBI:32682

subject_name: L-argininium

object_name: Prediabetes


subject: CHEBI:32682

object_name: Impaired glucose tolerance


subject: CHEBI:32682

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:32682

object_name: metabolic syndrome X


subject: CHEBI:32682

object_name: Insulin resistance


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:40618

subject_name: Pimagedine

object_name: diabetic retinopathy


subject: MESH:C000721066

object_name: kidney failure


subject: CHEBI:50858

subject_name: corticosteroid

object_name: rheumatoid arthritis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C4727560

object_name: lung cancer


subject: UMLS:C4727560

object_name: lung neoplasm


subject: UMLS:C4727560

object_name: lung carcinoma


subject: CHEBI:178199

subject_name: Sotorasib


subject: CHEBI:178199


subject: CHEBI:178199


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: melanoma


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: UNII:BK459F050X


subject: UNII:BK459F050X


subject: UNII:BK459F050X


subject: UNII:BK459F050X

object_name: non-small cell lung carcinoma


subject: UNII:BK459F050X

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:BK459F050X

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Underdosing of unspecified general anesthetics


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Non-Cancer Diagnosis


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Wound sepsis


subject: CHEBI:23066

subject_name: cephalosporin


subject: CHEMBL.COMPOUND:CHEMBL5482975

subject_name: CEPHALOSPORIN


subject: UMLS:C4706514

subject_name: Cephalosporin product


subject: UNII:9628AJ27JA

subject_name: Presatovir

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:16VY3TM7ZO

object_name: Stage IV Lung Cancer AJCC v7


subject: UNII:16VY3TM7ZO

object_name: Stage IV Lung Cancer AJCC v6


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: CHEBI:29228

subject_name: FLUORIDE

object_name: White Spot Lesion


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: CHEBI:134674

subject_name: Yosprala

object_name: Platelet aggregation test result


subject: UMLS:C5204486

subject_name: Imsapepimut


subject: UMLS:C5577550

subject_name: nivolumab / relatlimab


subject: UNII:843G0TDV51

object_name: colorectal cancer


subject: UNII:843G0TDV51

object_name: colorectal carcinoma


subject: UNII:843G0TDV51

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: breast neoplasm


subject: UMLS:C3827082


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1


subject: UMLS:C0003241

subject_name: Antibodies


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: CHEBI:132082

subject_name: Entinostat


subject: UNII:958AQ7B6R1

subject_name: Eprotirome

object_name: Familial hypercholesterolemia - heterozygous


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: Hyperplasia of the endometrium


subject: CHEBI:135947

object_name: osteoporosis


subject: CHEBI:135947

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:135947

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:135947

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:3663


subject: CHEBI:33369

subject_name: cerium


subject: CHEBI:33369


subject: CHEBI:33369


subject: CHEBI:33369


subject: CHEBI:33369


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: bilineal acute myeloid leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Infant Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Infant T Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: T-cell childhood acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Alzheimer disease


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C4745029

subject_name: HLX 10

object_name: Childhood Solid Neoplasm


subject: UMLS:C4745029

object_name: Solid Neoplasm


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: childhood low-grade glioma


subject: CHEBI:58097

object_name: Femoroacetabular impingement


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:135642

subject_name: Cinitapride

object_name: dyspepsia


subject: CHEBI:135642

object_name: Dyspepsia, CTCAE


subject: UMLS:C1121746

subject_name: BIRB 796

object_name: rheumatoid arthritis


subject: CHEBI:8499

subject_name: Propranolol

object_name: cerebral cavernous malformation 1


subject: CHEBI:8499

object_name: famililal cerebral cavernous malformations


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: Ischemic stroke


subject: UMLS:C0085826

object_name: atrial fibrillation


subject: UMLS:C0085826

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0085826

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0085826

object_name: Atherothrombosis


subject: UMLS:C0354604

subject_name: oral anticoagulants


subject: CHEBI:9144

subject_name: Silibinin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:125451

subject_name: silymarin


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: diabetic neuropathy


subject: UMLS:C3529192


subject: UMLS:C5667044

subject_name: Botanical-based Agent NBT-NM108

object_name: Metastatic Colon Carcinoma


subject: UMLS:C5667044

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C5667044

object_name: Stage IVC Colon Cancer AJCC v8


subject: UMLS:C5667044

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C5667044

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:91899

object_name: Respiratory Sounds


subject: CHEBI:3207

subject_name: Budesonide


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Heart Disease Risk Factors


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: PR:000007022

subject_name: ETS-related transcription factor Elf-3

object_name: Fabry disease


subject: CHEBI:193615

object_name: appendix cancer


subject: CHEBI:193615

object_name: appendix carcinoma


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine

object_name: colorectal cancer


subject: UMLS:C0947603

object_name: colorectal carcinoma


subject: UMLS:C0947603

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0947603


subject: UMLS:C0947603


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: digestive system cancer


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:63606


subject: UMLS:C5908033

subject_name: Anti-PD-L1/VEGF/TGF-beta Trispecific Antibody DR30206


subject: UMLS:C4760648


subject: UMLS:C0699857

subject_name: Nitrate

object_name: sarcopenia


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Pregnant


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Medication interaction potentiation


subject: UNII:I60W9520VV

subject_name: Vadadustat


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: skin neoplasm


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C4287754

subject_name: Ragifilimab

object_name: head and neck squamous cell carcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: fallopian tube carcinoma


subject: UNII:15C2VL427D

object_name: fallopian tube cancer


subject: UNII:15C2VL427D

object_name: Recurrent ovarian cancer


subject: UNII:15C2VL427D

object_name: peritoneum cancer


subject: CHEBI:9907

subject_name: ursodiol

object_name: classic familial adenomatous polyposis


subject: CHEBI:9907

object_name: Polyp of duodenum


subject: CHEBI:9907

object_name: duodenum cancer


subject: CHEBI:9907

object_name: tumor of duodenum


subject: CHEBI:25805

subject_name: oxygen atom

object_name: abscess


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:234073

subject_name: Fenebrutinib

object_name: urticaria


subject: CHEBI:234073

object_name: reported urticaria (physical finding)


subject: CHEBI:234073

object_name: Urticaria, CTCAE


subject: UMLS:C3896852


subject: UMLS:C3896852


subject: UMLS:C3896852


subject: UNII:Z4HZ70S62Q

subject_name: Unesbulin

object_name: ovarian cancer


subject: UNII:Z4HZ70S62Q

object_name: ovarian neoplasm


subject: UNII:Z4HZ70S62Q

object_name: ovarian carcinoma


subject: CHEBI:135515

subject_name: Bendamustine

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:135515

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:135515

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:135515

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:135515

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:135515

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:90998

subject_name: alvocidib hydrochloride

object_name: Refractory acute myeloid leukemia


subject: CHEBI:90998

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C2709282

subject_name: Alvocidib Hydrochloride


subject: UMLS:C2709282


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Anorexia


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: cancer


subject: UMLS:C5848866

object_name: neoplasm


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Adverse effects


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: lung carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:6095520

object_name: ovarian hyperstimulation syndrome


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: CHEBI:3309

subject_name: Calcium gluconate


subject: UMLS:C5226790

object_name: metabolic disease


subject: UMLS:C1567379

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: macrophage activation syndrome


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C5963122

object_name: pancreatic adenocarcinoma


subject: UMLS:C5963122

object_name: non-small cell lung carcinoma


subject: UMLS:C5963122

object_name: colorectal neoplasm


subject: UMLS:C5963122

object_name: Mesothelioma


subject: UMLS:C5963122

object_name: mesothelial neoplasm


subject: UMLS:C5963122

object_name: malignant mesothelioma


subject: UMLS:C5963122

object_name: ovarian cancer


subject: UMLS:C5963122

object_name: ovarian neoplasm


subject: CHEBI:9907

object_name: hepatic encephalopathy


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: EXCESS LMW-DNA


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: gestational trophoblastic neoplasm


subject: UMLS:C4287697


subject: CHEBI:8802

subject_name: Remifentanil

object_name: hematologic disorder


subject: CHEBI:8802

object_name: neoplasm


subject: CHEBI:35476

subject_name: antipsychotic agent

object_name: Psychotic episodes


subject: CHEBI:35476

object_name: metabolic disease


subject: UMLS:C0040615

subject_name: Antipsychotic Agents


subject: UMLS:C0040615


subject: CHEBI:67271

object_name: invasive breast carcinoma


subject: CHEBI:91951

object_name: Estrogen Receptor Positive


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:49140

object_name: rectal carcinoma


subject: CHEBI:49140

object_name: rectal cancer


subject: CHEBI:49140

object_name: Childhood Rectal Carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C3709490

subject_name: sunflower lecithin

object_name: dry eye syndrome


subject: UMLS:C3709490

object_name: Posterior blepharitis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:136519

subject_name: n-butyl isocyanate

object_name: Renal transplant rejection


subject: CHEBI:136519

object_name: HIV infection


subject: PUBCHEM.COMPOUND:21130

subject_name: imidazole mustard


subject: PUBCHEM.COMPOUND:21130


subject: CHEBI:2569

subject_name: Alfentanil

object_name: Hypoxemia


subject: CHEBI:2569

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEBI:31312

subject_name: Bucillamine

object_name: gout


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: lung cancer


subject: PUBCHEM.COMPOUND:21874242

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:21874242

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:21874242

object_name: small cell carcinoma


subject: UMLS:C0701947

subject_name: Prolastin


subject: CHEBI:176334

object_name: acute myeloid leukemia


subject: CHEBI:15383

object_name: Childhood Breast Carcinoma


subject: CHEBI:15383

object_name: breast carcinoma


subject: CHEBI:15383

object_name: breast cancer


subject: CHEBI:15384

subject_name: limonene


subject: CHEBI:15384


subject: CHEBI:15384


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: digestive system neuroendocrine neoplasm


subject: GTOPDB:9592

object_name: Neuroendocrine carcinoma of prostate


subject: GTOPDB:9592

object_name: malignant pleural mesothelioma


subject: GTOPDB:9592

object_name: anal margin carcinoma


subject: GTOPDB:9592

object_name: anal squamous cell carcinoma


subject: GTOPDB:9592

object_name: small cell lung carcinoma


subject: GTOPDB:9592

object_name: Childhood Soft Tissue Sarcoma


subject: GTOPDB:9592

object_name: Adult Soft Tissue Sarcoma


subject: GTOPDB:9592

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: GTOPDB:9592

object_name: colorectal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Childhood Neuroblastoma


subject: CHEBI:45716

object_name: neuroblastoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: thyroid tumor


subject: CHEBI:119915

object_name: thyroid cancer


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Trismus


subject: CHEBI:76128

object_name: Trismus, CTCAE


subject: CHEBI:76128

object_name: Inflammatory Response


subject: CHEBI:76128

object_name: Impacted tooth


subject: CHEBI:16118

subject_name: Berberine


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Insulin resistance


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: heart disorder


subject: UMLS:C3541386

object_name: coronary artery disorder


subject: UMLS:C3541386

object_name: coronary atherosclerosis


subject: UMLS:C3541386

object_name: cardiovascular disorder


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: UMLS:C3537250


subject: UMLS:C3537250


subject: UMLS:C3537250


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: UMLS:C3714615


subject: UMLS:C3714615


subject: UMLS:C3714615


subject: UMLS:C0301869

subject_name: Immunostimulating conjugate (antigen)


subject: UMLS:C0301869


subject: UMLS:C0301869


subject: UMLS:C0301869


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: autoimmune lymphoproliferative syndrome type 1


subject: CHEBI:168243

object_name: autoimmune lymphoproliferative syndrome


subject: CHEBI:168243

object_name: Lymphadenopathy


subject: CHEBI:168243

object_name: hypersplenism


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UNII:I5590ES2QZ

subject_name: Fosbretabulin

object_name: Polypoidal choroidal vasculopathy


subject: PUBCHEM.COMPOUND:24996163


subject: PUBCHEM.COMPOUND:16130933

subject_name: SOVATELITIDE

object_name: Acute Ischemic Stroke


subject: PUBCHEM.COMPOUND:16130933

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:18007905

subject_name: Sovateltide


subject: PUBCHEM.COMPOUND:18007905


subject: UNII:11X778QIZS

subject_name: sovateltide


subject: UNII:11X778QIZS


subject: UMLS:C2348442


subject: UMLS:C2348442


subject: UMLS:C4042170

object_name: hyperaldosteronism


subject: UMLS:C4042170

object_name: Cushing syndrome


subject: UMLS:C4042170

object_name: adrenal gland hyperfunction


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Heartburn


subject: CHEBI:7514

object_name: Gastric reflux (finding)


subject: UMLS:C4548795

object_name: Crohn disease


subject: CHEBI:15365

subject_name: Aspirin

object_name: bladder tumor


subject: CHEBI:15365

object_name: Hematuria, CTCAE


subject: CHEBI:15365

object_name: Hematuria


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: chromosomal disorder


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Childhood Astrocytoma


subject: CHEBI:17549

object_name: astrocytic tumor


subject: CHEBI:17549

object_name: astrocytoma


subject: UNII:10521U3EQA

object_name: narcolepsy


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:52943456

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:52943456

object_name: malignant epithelial tumor of ovary


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: stuttering


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: breast disorder


subject: CHEBI:3215

object_name: breast neoplasm


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Childhood Breast Carcinoma


subject: CHEBI:119915

object_name: breast carcinoma


subject: CHEBI:119915

object_name: breast cancer


subject: CHEBI:119915


subject: CHEBI:119915


subject: MESH:C532829

subject_name: fuzheng huayu

object_name: primary biliary cholangitis


subject: MESH:C000655130

subject_name: DSGOST

object_name: familial cold autoinflammatory syndrome


subject: MESH:C000655130

object_name: Cold Hypersensitivity


subject: MESH:C000655130

object_name: familial cold autoinflammatory syndrome 1


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Prader-Willi syndrome


subject: UMLS:C1099192


subject: CHEBI:91402

subject_name: linsitinib

object_name: neoplasm


subject: CHEBI:91402

object_name: cancer


subject: UMLS:C2346449

subject_name: OSI 906


subject: UMLS:C2346449


subject: CHEBI:63589

subject_name: Etravirine

object_name: Inflammation


subject: CHEBI:63589

object_name: type 2 diabetes mellitus


subject: CHEBI:63589

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:92045019

object_name: Uncomplicated malaria


subject: PUBCHEM.COMPOUND:92045019

object_name: Plasmodium falciparum malaria


subject: PUBCHEM.COMPOUND:92045019

object_name: Asymptomatic Diseases


subject: UNII:8D81JS19ET

subject_name: ferroquine


subject: UNII:8D81JS19ET


subject: UNII:8D81JS19ET


subject: GTOPDB:9972


subject: GTOPDB:9972


subject: GTOPDB:9972


subject: PUBCHEM.COMPOUND:66586232

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:66586232

object_name: Barrett esophagus


subject: PUBCHEM.COMPOUND:66586232

object_name: peptic esophagitis


subject: PUBCHEM.COMPOUND:66586232

object_name: Gastro-esophageal reflux disease with esophagitis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: CHEBI:3614


subject: UMLS:C5198740

object_name: acidosis


subject: UMLS:C5198740

object_name: Acidosis, CTCAE


subject: PR:000023743

subject_name: protein RhsA

object_name: breast carcinoma


subject: PR:000023743

object_name: breast cancer


subject: PR:000023743

object_name: Chemotherapy induced neutropenia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Carcinoma liver resectable


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:14497139

subject_name: Pegargiminase


subject: CHEMBL.COMPOUND:CHEMBL3137346

subject_name: PEGARGIMINASE


subject: UMLS:C4721782


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: myeloproliferative neoplasm


subject: UMLS:C5552956

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C2346492

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C2346492

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C2346492

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Drug usage


subject: CHEBI:2453

object_name: Drug use history


subject: CHEBI:2453

object_name: Encounter due to drug use


subject: CHEBI:132774

subject_name: Roxadustat

object_name: kidney failure


subject: UMLS:C3713379


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Cannabis use disorder


subject: PUBCHEM.COMPOUND:156612998

subject_name: Cotadutide

object_name: Hepatic impairment


subject: CHEBI:8382

subject_name: Prednisone

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:8382

object_name: Acute heart failure


subject: CHEBI:52763

object_name: Hypercholesterolemia


subject: UNII:4521NR0J09

object_name: ulcerative colitis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Colorectal cancer recurrent


subject: UMLS:C5783944

subject_name: Gallium Ga 68 FAP-CHX

object_name: neoplasm


subject: UMLS:C5783944

object_name: Tumor Mass


subject: UMLS:C2973894

object_name: atopic eczema


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Pancreatic adenocarcinoma resectable


subject: GTOPDB:4942

object_name: pancreatic neoplasm


subject: GTOPDB:4942

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:4942

object_name: malignant pancreatic neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: CHEBI:66964

subject_name: Dronabinol

object_name: psychosis


subject: CHEBI:60791

subject_name: Xylocard

object_name: obstructive sleep apnea syndrome


subject: UMLS:C3490133


subject: CHEBI:60799

subject_name: Esketamine

object_name: Hemodynamic instability


subject: GTOPDB:12990

subject_name: sintilimab

object_name: esophageal adenocarcinoma


subject: GTOPDB:12990

object_name: cervical adenocarcinoma


subject: GTOPDB:12990

object_name: adenocarcinoma


subject: GTOPDB:12990

object_name: bile duct adenocarcinoma


subject: GTOPDB:12990

object_name: gastroesophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:50695

subject_name: monobactam

object_name: ventilator-associated pneumonia


subject: CHEBI:27933

subject_name: beta-lactam antibiotic


subject: UMLS:C5781289

subject_name: beta Lactam Antibiotics


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: osteoarthritis


subject: UMLS:C3641087

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: major affective disorder 4


subject: CHEBI:26710

object_name: major affective disorder 7


subject: CHEBI:26710

object_name: bipolar disorder


subject: CHEBI:26710

object_name: major affective disorder 6


subject: CHEBI:26710

object_name: major affective disorder 2


subject: CHEBI:26710

object_name: major affective disorder 8


subject: CHEBI:26710

object_name: major affective disorder 9


subject: CHEBI:26710

object_name: major affective disorder 1


subject: CHEBI:26710

object_name: major affective disorder 5


subject: CHEBI:45783

subject_name: Imatinib

object_name: C-kit gene mutation


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:85078

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:154723996

subject_name: Heme arginate

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:154723996

object_name: Acute Kidney Injury, CTCAE


subject: UNII:R1B526117P


subject: UNII:R1B526117P


subject: CHEBI:62466

subject_name: Prolycopene

object_name: aneurysm


subject: CHEBI:62466

object_name: subarachnoid hemorrhage


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:15948


subject: CHEBI:7466

subject_name: Nandrolone

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:7466

object_name: aplastic anemia


subject: CHEBI:7466

object_name: idiopathic aplastic anemia


subject: CHEBI:7466

object_name: interstitial lung disease 1


subject: CHEBI:7466

object_name: interstitial lung disease 2


subject: CHEBI:7466

object_name: bone marrow failure syndrome


subject: CHEBI:7466

object_name: Telomere Shortening


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Primary Insomnia


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: multiple symmetric lipomatosis


subject: PUBCHEM.COMPOUND:152165

object_name: Pericardial Effusion Related to COVID-19


subject: PUBCHEM.COMPOUND:152165

object_name: pericardial effusion


subject: PUBCHEM.COMPOUND:152165

object_name: Pericardial Effusion, CTCAE


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: cataract


subject: UNII:6GNT3Y5LMF

object_name: Cataract, CTCAE 3.0


subject: UNII:6GNT3Y5LMF

object_name: Cataract, CTCAE 5.0


subject: UNII:6GNT3Y5LMF

object_name: cataract on exam (physical finding)


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: UMLS:C3491293

object_name: Normal drug tolerance


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline


subject: UNII:07896928ZC


subject: CHEBI:6916

subject_name: Mexiletine

object_name: dystonia


subject: CHEBI:6916

object_name: blepharospasm


subject: CHEBI:6916

object_name: Muscle spasm


subject: CHEBI:6916

object_name: Hyperkinesia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: mucosal melanoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: ocular melanoma


subject: UMLS:C2346820


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic Anal Canal Carcinoma


subject: CHEBI:31348

object_name: Anal cancer recurrent


subject: CHEBI:31348

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIIB Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: cloacogenic carcinoma


subject: CHEBI:31348

object_name: anus basaloid carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355

object_name: anal margin carcinoma


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: anal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Mantle cell lymphoma refractory


subject: CHEBI:63791

object_name: indolent B-cell non-Hodgkin lymphoma


subject: CHEBI:63791


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: B-cell lymphoma recurrent


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: refractory hairy cell leukemia


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:O43472U9X8

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: Follicular lymphoma refractory


subject: UMLS:C3897088

object_name: Follicular lymphoma recurrent


subject: UMLS:C3897088

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: UMLS:C3897088

object_name: B-cell lymphoma refractory


subject: UMLS:C3897088

object_name: B-cell small lymphocytic lymphoma refractory


subject: UMLS:C3897088


subject: UMLS:C3897088

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C3897088

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C3897088

object_name: Marginal zone lymphoma refractory


subject: UMLS:C3897088


subject: UMLS:C3897088


subject: CHEBI:16737

subject_name: Creatinine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:16737

object_name: amyotrophic lateral sclerosis


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: pelvic organ prolapse


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Advanced Pancreatic Adenocarcinoma


subject: CHEBI:71954

object_name: triple-negative breast carcinoma


subject: CHEBI:71954

object_name: Stomach cancer


subject: CHEBI:71954

object_name: gastric cancer


subject: CHEBI:71954

object_name: Gastroesophageal junction cancer


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: Carcinoma breast stage IV


subject: UMLS:C2830069

object_name: metastatic colorectal cancer


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: UMLS:C2830069


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: Fused vertebrae


subject: CHEBI:91414

subject_name: Adavosertib

object_name: small cell lung carcinoma


subject: UMLS:C4053677


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C0001645

object_name: systolic heart failure


subject: UMLS:C5575602

subject_name: Cell Culture Serum

object_name: lung cancer


subject: UMLS:C5575602

object_name: lung neoplasm


subject: UMLS:C5575602

object_name: lung carcinoma


subject: UMLS:C5575602

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5575602

object_name: pneumonitis


subject: UMLS:C5575602

object_name: Pneumonitis, CTCAE


subject: CHEBI:64198

subject_name: Dimercaprol


subject: CHEBI:64198


subject: CHEBI:64198


subject: CHEBI:64198


subject: CHEBI:64198


subject: CHEBI:64198


subject: CHEBI:6801

subject_name: Metformin

object_name: myocardial ischemia


subject: CHEBI:6801

object_name: Family history of ischemic heart disease


subject: CHEBI:74707

subject_name: Met-Met

object_name: type 2 diabetes mellitus


subject: CHEBI:53458


subject: CHEBI:6121

subject_name: Ketamine

object_name: cholangitis


subject: CHEBI:6121

object_name: pancreatitis


subject: CHEBI:6121

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:6121

object_name: Pancreatitis, CTCAE 3.0


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: Adult Non-Hodgkin Lymphoma


subject: DRUGBANK:DB16582

object_name: Childhood Non-Hodgkin Lymphoma


subject: DRUGBANK:DB16582

object_name: mantle cell lymphoma


subject: UMLS:C3541932

subject_name: Moringa oleifera extract

object_name: malnutrition


subject: UMLS:C3541932

object_name: Growth delay


subject: UMLS:C3541932

object_name: Failure to Thrive


subject: UMLS:C3541932

object_name: Wasting


subject: UMLS:C3541932

object_name: Cachexia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Head and neck cancer stage IV


subject: UNII:2S9ZZM9Q9V

object_name: carcinoma of parotid gland


subject: UNII:2S9ZZM9Q9V

object_name: parotid gland cancer


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Thyroid Gland Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785

object_name: thyroid gland carcinoma


subject: CHEBI:114785


subject: CHEBI:114785

object_name: thyroid cancer


subject: CHEBI:114785

object_name: melanoma


subject: UMLS:C5238362

subject_name: EGFR/HER2 Inhibitor DZD9008

object_name: Hepatic impairment


subject: DRUGBANK:DB16537

subject_name: Bacillus clausii

object_name: digestive system disorder


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: laryngeal carcinoma


subject: CHEBI:150712

object_name: larynx cancer


subject: CHEBI:150712

object_name: head and neck squamous cell carcinoma


subject: CHEBI:150712

object_name: head and neck neoplasm


subject: CHEBI:150712

object_name: voice disorders


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:5281767

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: radiation proctitis


subject: UNII:2Q1GS25JWN

subject_name: AVOTERMIN

object_name: Wound healed (finding)


subject: UMLS:C3179443

subject_name: avotermin


subject: UMLS:C3661275

object_name: clear cell renal carcinoma


subject: UMLS:C3661275

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: UMLS:C4054273


subject: UMLS:C4054273


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Skin - other


subject: UMLS:C3896806


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b


subject: UMLS:C0021741

subject_name: Actimmune


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Hiccough


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:3962


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:49668

subject_name: Gefitinib

object_name: liver cancer


subject: CHEBI:49668

object_name: liver neoplasm


subject: CHEBI:49668

object_name: Adult Liver Carcinoma


subject: CHEBI:2955

subject_name: Azithromycin

object_name: malnutrition


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154

object_name: hereditary endocrine growth disease


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: CHEBI:94807


subject: UMLS:C0939333

subject_name: Estradiol Patch

object_name: Perimenopausal disorder


subject: UMLS:C0939333

object_name: Emotional Stress


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Encounter due to In vitro fertilization


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252

object_name: female infertility


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: BH4-deficient hyperphenylalaninemia A


subject: UNII:9810NUL4D1

subject_name: Carmoterol

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0701307

subject_name: Cytovene

object_name: Childhood Brain Neoplasm


subject: UMLS:C0701307

object_name: brain cancer


subject: UMLS:C0701307

object_name: brain neoplasm


subject: UMLS:C0701307

object_name: Neoplasm Metastasis


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284


subject: CHEBI:465284


subject: CHEBI:465284


subject: DRUGBANK:DB10708

subject_name: Flax seed

object_name: Postprandial hyperglycemia


subject: PR:000022642

subject_name: flagellar basal-body rod protein FlgF


subject: UMLS:C2697920

object_name: peritoneal carcinomatosis


subject: PUBCHEM.COMPOUND:6450536

object_name: chronic hepatitis C virus infection


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: acute coronary syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: Caesarean section


subject: CHEBI:8774

subject_name: Ramipril

object_name: idiopathic spontaneous coronary artery dissection


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:230905

subject_name: Ribociclib

object_name: gastric neuroendocrine tumor, well differentiated, low or intermediate grade


subject: CHEBI:230905

object_name: gastric neuroendocrine neoplasm


subject: CHEBI:230905

object_name: Carcinoid tumor of the duodenum


subject: CHEBI:230905

object_name: functional pancreatic neuroendocrine tumor


subject: CHEBI:230905

object_name: non-functional pancreatic neuroendocrine tumor


subject: CHEBI:230905

object_name: Low Grade Lung Neuroendocrine Neoplasm


subject: CHEBI:230905

object_name: thymus neoplasm


subject: CHEBI:230905

object_name: Intermediate Grade Lung Neuroendocrine Neoplasm


subject: CHEBI:230905

object_name: Advanced Digestive System Neuroendocrine Neoplasm


subject: GTOPDB:9290

subject_name: elezanumab

object_name: spinal cord injury


subject: UNII:SK1LVT23A1

subject_name: ELEZANUMAB


subject: UMLS:C5139889


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: binge eating


subject: UNII:889I657R9P

object_name: Binge eating behavior


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: UNII:987R943R3P


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:9137


subject: CHEBI:94686

subject_name: Orlistat


subject: CHEBI:94686


subject: PUBCHEM.COMPOUND:135483998

object_name: Reduced blood folate concentration


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: MESH:C000706131

object_name: Alzheimer disease


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: Colorectal Adenocarcinoma Metastatic in the Liver


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: MESH:C000618615

subject_name: Fluzone High-Dose

object_name: outcomes general quality of life


subject: MESH:C000618615

object_name: Perceived quality of life


subject: MESH:C000618615

object_name: Good quality of life


subject: MESH:C000618615

object_name: Injection Site Reaction


subject: MESH:C000618615

object_name: Injection Site Reaction, CTCAE


subject: MESH:C000618615

object_name: Adverse drug response


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: acne


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: no feeling or sensation of skin


subject: UMLS:C3540792

object_name: Sensory Loss


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C5417769

subject_name: V-Boost

object_name: glioblastoma


subject: UMLS:C5417769

object_name: Brain Stem Glioblastoma


subject: UMLS:C5417769

object_name: glioma susceptibility 1


subject: UMLS:C5417769

object_name: Intracranial glioma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: dysplasia of cervix


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:89992620

subject_name: AVENCIGUAT

object_name: liver disorder


subject: UNII:ZA7KTB4PSP


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: portal hypertension


subject: PUBCHEM.COMPOUND:73151030


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: Menopause present (finding)


subject: CHEBI:135947

object_name: Menopause


subject: UMLS:C0018061

subject_name: Gonadotropins

object_name: infertility


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]


subject: UMLS:C0723783

subject_name: Toprol-XL

object_name: heart valve disorder


subject: UMLS:C0723783

object_name: heart disorder


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: inflammatory bowel disease 1


subject: CHEBI:46195

object_name: Crohn disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C0993954

subject_name: LYMPHOCYTE IMMUNE GLOBULIN, ANTITHYMOCYTE GLOBULIN, EQUINE, PARENTERAL, 250 MG ADMINISTERED


subject: UMLS:C0993954


subject: UMLS:C0305055

subject_name: lymphocyte immune globulin


subject: UMLS:C0305055


subject: CHEBI:3219

subject_name: Bupropion

object_name: cocaine abuse


subject: CHEBI:45716

subject_name: Vorinostat

object_name: malignant glioma


subject: CHEBI:45716

object_name: brain cancer


subject: DRUGBANK:DB10666

subject_name: Arabica coffee bean

object_name: Overweight and obesity


subject: CHEBI:44915

subject_name: Propofol

object_name: supratentorial cancer


subject: CHEBI:8802

subject_name: Remifentanil


subject: RXCUI:798361

subject_name: Havrix

object_name: Transplant-Related Malignant Neoplasm


subject: CHEBI:82354

subject_name: Nitrogen mustard N-oxide

object_name: Hodgkin Disease


subject: CHEBI:37598

subject_name: nitrogen mustard


subject: CHEBI:28925

subject_name: Mechlorethamine


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: microinvasive gastric cancer


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: heart failure


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM

object_name: macular degeneration


subject: UNII:L63605PZ70

object_name: age-related macular degeneration


subject: UNII:L63605PZ70

object_name: retinitis pigmentosa 30


subject: UNII:L63605PZ70

object_name: choroidal neovascularization


subject: UNII:L63605PZ70

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: CHEBI:135875

subject_name: Talaporfin


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: UNII:79R3ZF226Y


subject: UNII:79R3ZF226Y


subject: UNII:79R3ZF226Y


subject: UNII:79R3ZF226Y


subject: UNII:79R3ZF226Y


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:30780


subject: RXCUI:36572

subject_name: Sinemet

object_name: stroke disorder


subject: RXCUI:36572

object_name: cerebrovascular disorder


subject: RXCUI:36572

object_name: Stroke (heart beat)


subject: RXCUI:36572

object_name: Stroke, CTCAE


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Medication Nonadherence


subject: CHEBI:5613

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: pustulosis palmaris et plantaris


subject: UNII:K6K4B9Z5TV

subject_name: Ivarmacitinib


subject: UNII:6ST3ZF52WB

subject_name: Carboxyamidotriazole

object_name: Metastatic non-small cell lung cancer


subject: UNII:6ST3ZF52WB

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:6ST3ZF52WB

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Hypoxemic Respiratory Failure


subject: CHEBI:15379

subject_name: Oxygen


subject: PUBCHEM.COMPOUND:3685

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Liver Carcinoma


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: PUBCHEM.COMPOUND:90488848

object_name: Primary gout


subject: PUBCHEM.COMPOUND:90488848

object_name: Gout attack


subject: GTOPDB:1331

subject_name: ACTH


subject: GTOPDB:1331


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: UMLS:C3539087


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:3892


subject: UMLS:C5779650

object_name: biliary atresia


subject: CHEBI:90881

subject_name: Camptosar

object_name: neuroendocrine carcinoma


subject: CHEBI:90881

object_name: Cutaneous Merkel Cell Carcinoma


subject: CHEBI:90881

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: allergic bronchopulmonary aspergillosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:C000722715

subject_name: LVRNA009 COVID-19 vaccine


subject: PUBCHEM.COMPOUND:129130827

subject_name: Bictegravir

object_name: Drug usage


subject: PUBCHEM.COMPOUND:129130827

object_name: Drug use history


subject: PUBCHEM.COMPOUND:129130827

object_name: Encounter due to drug use


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:31536


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:72370618


subject: PUBCHEM.COMPOUND:72370618


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:6I3O3W6O3B

object_name: non-Hodgkin lymphoma


subject: UNII:6I3O3W6O3B

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:6I3O3W6O3B

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Partial Seizure


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C0963941

object_name: impotence


subject: UMLS:C0963941

object_name: Erectile Dysfunction, CTCAE


subject: UMLS:C0963941

object_name: Erectile dysfunction


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:135436482

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:135436482

object_name: Childhood Rectal Carcinoma


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: CHEBI:600103

subject_name: daptomycin

object_name: Sepsis


subject: CHEBI:600103

object_name: Sepsis, CTCAE


subject: UMLS:C1314954

subject_name: Pituitary Adenylate Cyclase Activating Polypeptide 38

object_name: Common Migraine


subject: UMLS:C5239856

subject_name: Vaccine product containing only Japanese encephalitis virus antigen (medicinal product)

object_name: Japanese encephalitis


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: liver neoplasm


subject: CHEBI:72317

object_name: Adult Liver Carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C4330852

subject_name: Oligomeric Procyanidin Complex

object_name: Parkinson disease


subject: UMLS:C0733521

subject_name: Ara-C

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: DRUGBANK:DB14317

subject_name: Pomegranate

object_name: premenstrual tension


subject: DRUGBANK:DB14317

object_name: polydactyly-myopia syndrome


subject: UMLS:C1961993

subject_name: pomegranate extract


subject: UMLS:C1961993


subject: CHEBI:23965

subject_name: estradiol

object_name: Cognitive impairment


subject: CHEBI:23965

object_name: Executive dysfunction


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427

object_name: cardiovascular disorder


subject: CHEBI:6427


subject: CHEBI:6427

object_name: coronary microvascular disorder


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:15765

subject_name: Levodopa

object_name: amblyopia


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: UNII:ZNP5SNF9FY

object_name: schizophrenia


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: HPV-associated cervical carcinoma


subject: UNII:M89N0Q7EQR

object_name: vulva cancer


subject: UNII:M89N0Q7EQR

object_name: vulva carcinoma


subject: UNII:M89N0Q7EQR

object_name: HPV-related carcinoma


subject: UNII:M89N0Q7EQR

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: UNII:M89N0Q7EQR

object_name: human papillomavirus-related squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Adenosquamous Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Cervical Adenocarcinoma


subject: UNII:M89N0Q7EQR


subject: UNII:M89N0Q7EQR

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139945

object_name: end stage renal failure


subject: UMLS:C5139945

object_name: Chronic uremia


subject: GTOPDB:11366

subject_name: osocimab


subject: GTOPDB:11366


subject: UNII:EK5V9UL3WL


subject: UNII:EK5V9UL3WL


subject: UMLS:C5139912


subject: UMLS:C5139912


subject: UMLS:C5392750

object_name: asthma


subject: PUBCHEM.COMPOUND:50985821

subject_name: Metarrestin

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:50985821

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:50985821

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:50985821

object_name: malignant peripheral nerve sheath tumor


subject: PUBCHEM.COMPOUND:50985821

object_name: adult malignant schwannoma


subject: PUBCHEM.COMPOUND:50985821

object_name: childhood malignant schwannoma


subject: PUBCHEM.COMPOUND:50985821

object_name: colorectal neoplasm


subject: MESH:C000633774

subject_name: metarrestin


subject: MESH:C000633774


subject: MESH:C000633774


subject: MESH:C000633774


subject: MESH:C000633774


subject: MESH:C000633774


subject: MESH:C000633774


subject: UMLS:C5666964

subject_name: VEGFR3 Inhibitor EVT801

object_name: Adult Solid Neoplasm


subject: UMLS:C3661059

object_name: hyperlipidemia


subject: UMLS:C3661059

object_name: hyperlipoproteinemia


subject: UMLS:C3661059

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C3661059

object_name: Serum lipids high (finding)


subject: CHEBI:149601

subject_name: Bempedoic acid


subject: CHEBI:149601


subject: CHEBI:149601


subject: CHEBI:8802

subject_name: Remifentanil

object_name: arteriovenous hemangioma/malformation


subject: CHEBI:8802

object_name: hemorrhage, intracerebral, susceptibility to


subject: CHEBI:8802

object_name: renal tubular dysgenesis


subject: CHEBI:8802

object_name: hepatitis, infectious canine


subject: CHEBI:8802

object_name: brain neoplasm


subject: CHEBI:29947

subject_name: glycine residue

object_name: alcohol abuse


subject: CHEBI:29947

object_name: alcohol dependence


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:10125

subject_name: Zolpidem

object_name: pervasive developmental disorder


subject: CHEBI:10125

object_name: autism


subject: CHEBI:10125

object_name: autism spectrum disorder


subject: CHEBI:145924

subject_name: Kaletra


subject: UMLS:C0939237

subject_name: lopinavir / ritonavir


subject: UMLS:C4305663

object_name: Chronic Regional Pain Syndrome


subject: UMLS:C4305663

object_name: rheumatoid arthritis


subject: UMLS:C4305663

object_name: Chronic low back pain


subject: UMLS:C4305663

object_name: osteoarthritis


subject: CHEBI:68590

subject_name: fidaxomicin

object_name: Clostridium infectious disease


subject: UMLS:C3493806

object_name: Drug Interactions


subject: CHEBI:110423

subject_name: Clodronic acid

object_name: Femur fracture


subject: UMLS:C3192374

subject_name: Nicotine Nasal Spray

object_name: Never smoked tobacco


subject: UMLS:C3192374

object_name: Non-smoker


subject: UMLS:C3192374

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3192374


subject: UMLS:C1443151

subject_name: Gum arabic antigen

object_name: Bowel incontinence


subject: UMLS:C1443151

object_name: Fecal Incontinence, CTCAE


subject: MESH:D006170

subject_name: Gum Arabic


subject: MESH:D006170


subject: UNII:1YTW0422YU

subject_name: Gum arabic


subject: UNII:1YTW0422YU


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: UMLS:C2093618


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: DRUGBANK:DB10451


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: DRUGBANK:DB11097


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:165446


subject: PUBCHEM.COMPOUND:24748

subject_name: Croscarmellose


subject: PUBCHEM.COMPOUND:24748


subject: CHEMBL.COMPOUND:CHEMBL1909054

subject_name: CARBOXYMETHYLCELLULOSE


subject: CHEMBL.COMPOUND:CHEMBL1909054


subject: UNII:K679OBS311

subject_name: Carboxymethylcellulose Sodium


subject: UNII:K679OBS311


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Other infantile cerebral palsy


subject: CHEBI:38940

subject_name: Sunitinib

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:38940

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:38940

object_name: Blast Phase


subject: CHEBI:38940

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:38940

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:38940

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:38940

object_name: chronic myelomonocytic leukemia


subject: CHEBI:38940

object_name: Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive


subject: CHEBI:38940

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:38940

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:38940

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:38940

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:38940

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:38940

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:38940

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:38940

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:38940

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:38940

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:38940

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:38940

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:38940

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:38940

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:38940

object_name: refractory hairy cell leukemia


subject: CHEBI:38940

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:38940

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:38940

object_name: mast cell leukemia


subject: CHEBI:38940

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:38940

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:38940

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:38940

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:38940

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:38940

object_name: acute undifferentiated leukemia


subject: CHEBI:38940

object_name: prolymphocytic leukemia


subject: CHEBI:38940

object_name: myelofibrosis


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:232342


subject: UNII:ANM9DBL9JT


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Enteral feeding intolerance


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Premature birth


subject: CHEBI:7565

object_name: Preterm labor without delivery


subject: CHEBI:7565

object_name: Preterm labor in third trimester with preterm delivery in third trimester


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage II Vaginal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage II vaginal cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Vaginal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Therapy-Related Toxicity


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:231347


subject: CHEBI:231347


subject: CHEBI:231347

object_name: stage III cervical cancer


subject: CHEBI:231347

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Cervical carcinoma stage IIA


subject: CHEBI:231347

object_name: Stage IIA Cervical Cancer AJCC v6


subject: CHEBI:231347

object_name: Stage IIA Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIA Cervical Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IB Cervical Cancer AJCC v8


subject: CHEBI:231347

object_name: stage IB cervical cancer


subject: CHEBI:231347

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Cervical carcinoma stage IIB


subject: CHEBI:231347

object_name: Stage IIB Cervical Cancer AJCC v8


subject: CHEBI:231347


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: breast cancer


subject: CHEBI:83766

subject_name: Olaparib

object_name: Oligometastatic malignant neoplasm


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: anemia


subject: CHEBI:66919

object_name: Anemia, CTCAE


subject: GTOPDB:12962

subject_name: sotatercept

object_name: myelofibrosis


subject: GTOPDB:12962


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: CHEBI:17066

subject_name: (R)-3-hydroxybutyric acid

object_name: Hyperketonemia


subject: CHEBI:17066

object_name: metabolic disease


subject: CHEBI:17066

object_name: myopathy


subject: UMLS:C0879272

object_name: ovarian cancer


subject: UMLS:C0879272

object_name: ovarian neoplasm


subject: UMLS:C0879272

object_name: ovarian carcinoma


subject: UMLS:C0879272

object_name: primary peritoneal carcinoma


subject: UMLS:C0879272

object_name: Primary Peritoneal Cancer


subject: UMLS:C0879272

object_name: fallopian tube carcinoma


subject: UMLS:C0879272

object_name: fallopian tube cancer


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:134991

subject_name: Frovatriptan

object_name: Medication overuse headache


subject: CHEBI:134991

object_name: Analgesic Overuse Headache


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: childhood malignant neoplasm


subject: UMLS:C4745070

object_name: refractory malignant neoplasm


subject: UMLS:C4745070

object_name: Refractory Neoplasm


subject: UMLS:C4745070

object_name: pediatric lymphoma


subject: UMLS:C4745070

object_name: pediatric meningioma


subject: UMLS:C4745070

object_name: Childhood Brain Neoplasm


subject: UMLS:C4745070

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C4745070

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C4745070

object_name: Neuroblastoma recurrent


subject: UMLS:C4745070

object_name: Childhood Neuroblastoma


subject: UMLS:C4745070

object_name: neuroblastoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:9TD681796G

subject_name: Sitafloxacin

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: CHEBI:4304

subject_name: sitafloxacin


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: endocarditis


subject: PUBCHEM.COMPOUND:9852982

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:9852982

object_name: Bacteremia, CTCAE


subject: CHEBI:600103

subject_name: daptomycin


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:63607


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: primary hyperparathyroidism


subject: PUBCHEM.COMPOUND:16129616

object_name: hypercalcemia


subject: PUBCHEM.COMPOUND:16129616

object_name: Hypercalcemia, CTCAE


subject: CHEBI:135973

subject_name: Miacalcic


subject: CHEBI:135973


subject: CHEBI:135973


subject: UNII:DF35I47HCM

subject_name: CALCITONIN


subject: UNII:DF35I47HCM


subject: UNII:DF35I47HCM


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:D6OMY2L0WA

object_name: B-cell neoplasm


subject: UNII:D6OMY2L0WA

object_name: Burkitt lymphoma


subject: UNII:D6OMY2L0WA

object_name: Childhood Burkitt Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Adult Burkitt Lymphoma


subject: UNII:D6OMY2L0WA

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UNII:D6OMY2L0WA

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UNII:D6OMY2L0WA

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: sleep apnea


subject: CHEBI:3654

object_name: Sleep Apnea, CTCAE


subject: CHEBI:2639

subject_name: Amiloride


subject: CHEBI:2639


subject: CHEBI:168426

subject_name: ethyl citrate

object_name: plasma cell myeloma


subject: CHEBI:168426

object_name: AL amyloidosis


subject: CHEBI:44915

subject_name: Propofol

object_name: impaired driving


subject: UMLS:C0008586

subject_name: Chromogranins

object_name: Infection


subject: UMLS:C0008586

object_name: infectious disease


subject: UMLS:C0008586

object_name: Adverse Event Associated with Infection


subject: MESH:D007466

subject_name: Iodophors


subject: MESH:D007466


subject: MESH:D007466


subject: CHEBI:29191

subject_name: hydroxyl

object_name: cancer


subject: CHEBI:29191

object_name: neoplasm


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: UMLS:C0700307


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:16234


subject: CHEBI:17234

subject_name: D-glucose

object_name: Diabetes


subject: CHEBI:17234

object_name: diabetes mellitus


subject: UMLS:C0982177

subject_name: GLUCOSE LIQUID

object_name: type 2 diabetes mellitus


subject: UMLS:C0982177


subject: UMLS:C0982177


subject: HMDB:HMDB0000668

subject_name: Hematoporphyrin IX

object_name: Cholangiocarcinoma non-resectable


subject: PUBCHEM.COMPOUND:11103

subject_name: Hematoporphyrin


subject: CHEMBL.COMPOUND:CHEMBL317840

subject_name: HAEMAPORPHYRIN


subject: CHEBI:36162

subject_name: Hemoporfin


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Liver Fibrosis


subject: CHEBI:49603

subject_name: Lapatinib

object_name: acoustic neuroma


subject: CHEBI:49603

object_name: NF2-related schwannomatosis


subject: CHEBI:49603

object_name: vestibular schwannomatosis


subject: CHEBI:49603

object_name: Auditory Tumor


subject: UNII:SE2KH7T06F

object_name: luminal B breast carcinoma


subject: UNII:SE2KH7T06F

object_name: Basal-like


subject: UMLS:C4287766

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C3274746

subject_name: PVS-RIPO

object_name: melanoma


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: scoliosis


subject: CHEBI:84739

object_name: Infection


subject: CHEBI:84739

object_name: infectious disease


subject: CHEBI:84739

object_name: Adverse Event Associated with Infection


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:2637


subject: CHEBI:2637


subject: CHEBI:161680

subject_name: Aztreonam


subject: CHEBI:161680


subject: CHEBI:161680


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3515


subject: CHEBI:3515


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:51799

subject_name: Imipenem


subject: CHEBI:51799


subject: CHEBI:51799


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:190509


subject: UMLS:C0440016

subject_name: Allergenic extract

object_name: Hay fever


subject: DRUGBANK:DB14179

subject_name: Phleum pratense top


subject: UMLS:C1446714

subject_name: Phleum pratense allergenic extract


subject: DRUGBANK:DB10394

subject_name: Phleum pratense pollen


subject: CHEBI:47657

subject_name: Roflumilast

object_name: diffuse large B-cell lymphoma


subject: CHEBI:47657

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:47657

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: arteriovenous hemangioma/malformation


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: PUBCHEM.COMPOUND:54675783

object_name: aneurysm


subject: UMLS:C0378942

object_name: type 1 diabetes mellitus 1


subject: UNII:F7MN148019

object_name: macular degeneration


subject: UNII:F7MN148019

object_name: retinitis pigmentosa 30


subject: UNII:F7MN148019

object_name: retinal degeneration


subject: UNII:F7MN148019

object_name: eye disorder


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Allergy


subject: CHEBI:94559

object_name: History of allergies


subject: CHEBI:229573

object_name: alcohol abuse


subject: CHEBI:229573

object_name: alcohol dependence


subject: CHEBI:8633

subject_name: Puerarin


subject: CHEBI:8633


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: cervical carcinoma


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C3536851

subject_name: Calcium Channel Blocker [EPC]

object_name: type 2 diabetes mellitus


subject: UMLS:C3272840

subject_name: meningococcal polysaccharide vaccine (MPSV4)

object_name: meningococcal meningitis


subject: UMLS:C2960908

subject_name: Meningococcal vaccine component


subject: CHEBI:177597

subject_name: Fispemifene

object_name: chronic obstructive pulmonary disease


subject: CHEBI:177597

object_name: hypogonadism


subject: UMLS:C1880780

subject_name: fispemifene


subject: UMLS:C1880780


subject: PR:000013527

subject_name: pregnancy zone protein

object_name: Metastatic Renal Cell Carcinoma


subject: PR:000013527

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:2269

object_name: Genital mycoplasma infection


subject: PUBCHEM.COMPOUND:2269

object_name: cervicitis


subject: PUBCHEM.COMPOUND:2269

object_name: urethritis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54707177

subject_name: lymecycline


subject: PUBCHEM.COMPOUND:54707177


subject: PUBCHEM.COMPOUND:54707177


subject: CHEBI:59040

subject_name: Lymecycline


subject: CHEBI:59040


subject: CHEBI:59040


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Absence Seizure


subject: UNII:S276568KOY

subject_name: Gadopiclenol

object_name: prostate carcinoma


subject: UNII:S276568KOY

object_name: prostate cancer


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Paresis


subject: CHEBI:15927

object_name: Muscle weakness


subject: CHEBI:15927

object_name: cancer


subject: CHEBI:15927

object_name: neoplasm


subject: CHEBI:145751

subject_name: Asn-Arg


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:145751


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:5S371K6132

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UMLS:C4547969


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: UMLS:C5136861

subject_name: Cutaquig

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Mechanical ventilation finding


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: ulcerative colitis


subject: UNII:XRO4566Q4R

object_name: inflammatory bowel disease 1


subject: UMLS:C5417846

subject_name: LRP5 Antagonist BI 905681


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: kidney failure


subject: UNII:0AHT0IC02G

subject_name: FLOTETUZUMAB

object_name: Refractory acute myeloid leukemia


subject: UNII:0AHT0IC02G

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C3896731

subject_name: Flotetuzumab


subject: UMLS:C3896731


subject: CHEBI:145365

subject_name: Crenolanib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:145365

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: psychosis


subject: PUBCHEM.COMPOUND:9821941

object_name: Nonorganic psychosis


subject: PUBCHEM.COMPOUND:9821941

object_name: Psychosis, CTCAE


subject: PUBCHEM.COMPOUND:9914270

subject_name: Landiolol

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:9914270

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:9914270

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Adverse drug interaction


subject: CHEBI:47808

subject_name: Sulforaphane


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:45409

subject_name: Ritonavir

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: plasma cell myeloma


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: intracerebral hemorrhage


subject: DRUGBANK:DB17869

object_name: Autosomal dominant retinitis pigmentosa


subject: DRUGBANK:DB17869

object_name: retinitis


subject: DRUGBANK:DB17869

object_name: retinal disease


subject: DRUGBANK:DB17869

object_name: inherited retinal dystrophy


subject: DRUGBANK:DB17869

object_name: Eye Diseases, Hereditary


subject: DRUGBANK:DB17869

object_name: vision disorder


subject: DRUGBANK:DB17869

object_name: Peripheral visual field loss


subject: DRUGBANK:DB17869

object_name: eye disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Demonstrates adequate pain control


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Metastatic Breast Carcinoma


subject: CHEBI:4672

object_name: Advanced Breast Carcinoma


subject: CHEBI:4672

object_name: Advanced Prostate Carcinoma


subject: CHEBI:4672

object_name: Unresectable Solid Neoplasm


subject: CHEBI:4672

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: metastatic prostate carcinoma


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:AIQ4OWD0RA

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA

object_name: castration-resistant prostate carcinoma


subject: UNII:AIQ4OWD0RA

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA

object_name: Stage III Prostate Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:AIQ4OWD0RA


subject: UNII:AIQ4OWD0RA

object_name: triple-negative breast carcinoma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:77562

object_name: Embolism, Tumor


subject: CHEBI:77562

object_name: Neoplasm Metastasis


subject: CHEBI:77562

object_name: Solid Neoplasm


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: UMLS:C0003438

subject_name: antithrombin III

object_name: portal vein thrombosis


subject: UMLS:C0003438

object_name: Portal Vein Thrombosis, CTCAE


subject: UMLS:C0003438

object_name: liver cirrhosis


subject: UMLS:C0724532

subject_name: antithrombin III, human


subject: UMLS:C0724532


subject: UMLS:C0724532


subject: UMLS:C0723738

subject_name: Thrombate III


subject: UMLS:C0723738


subject: UMLS:C0723738


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED

object_name: lung cancer


subject: UMLS:C1321603

object_name: lung neoplasm


subject: UMLS:C1321603

object_name: lung carcinoma


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Renal anaemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: nephrotic syndrome


subject: UNII:4F4X42SYQ6

object_name: Nephrotic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:11597537

subject_name: tanzisertib

object_name: fibrosis


subject: PUBCHEM.COMPOUND:11597537

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:11597537

object_name: interstitial lung disease 2


subject: PUBCHEM.COMPOUND:11597537

object_name: pulmonary fibrosis


subject: PUBCHEM.COMPOUND:11597537

object_name: Pulmonary Fibrosis, CTCAE


subject: PUBCHEM.COMPOUND:11597537

object_name: interstitial lung disease


subject: UMLS:C3490878


subject: UMLS:C3490878


subject: UMLS:C3490878


subject: UMLS:C3490878


subject: UMLS:C3490878


subject: UMLS:C3490878


subject: UMLS:C5854417

subject_name: MALT1 Inhibitor ABBV-525

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5854417

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C5854417

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5854417

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5854417

object_name: non-Hodgkin lymphoma


subject: CHEBI:3745

subject_name: clindamycin

object_name: Staphylococcal Skin Infections


subject: CHEBI:3745

object_name: staphylococcal infection


subject: CHEBI:3745

object_name: folliculitis


subject: CHEBI:3745

object_name: Folliculitis, CTCAE


subject: CHEBI:3745

object_name: abscess


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: urolithiasis


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Adult Solid Neoplasm


subject: CHEBI:231005

object_name: Ovarian cancer stage III


subject: CHEBI:231005

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:231005

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pulmonary hypertension


subject: CHEMBL.COMPOUND:CHEMBL5315077

subject_name: TILMANOCEPT

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315077

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315077

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL5315077

object_name: Sentinel node (disorder)


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Childhood Solid Neoplasm


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Solid Neoplasm


subject: CHEBI:73614

subject_name: Met-Thr

object_name: pediatric osteosarcoma


subject: CHEBI:73614

object_name: Osteosarcoma


subject: CHEBI:73614


subject: CHEBI:73614


subject: CHEBI:73614


subject: CHEBI:33361

subject_name: meitnerium atom


subject: CHEBI:33361


subject: CHEBI:33361


subject: CHEBI:33361


subject: CHEBI:33361


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: PR:000010231


subject: PR:000010231


subject: PR:000010231